Videos

Olympic’s ‘Game-Changing’ Dry Eye Device

Olympic’s ‘Game-Changing’ Dry Eye Device

By Evan Munoz | July 23, 2019

Michael Gertner, Olympic Ophthalmics CEO, describes the company’s iTEAR neuromodulation device for dry eye as “a game changer” in this video from OIS@ASCRS. He also…

Read More
Companies to Watch: Novaliq - OIS

Companies to Watch: Novaliq

By OIS Contributor | July 23, 2019

In this video, Bernhard Günther, president of Novaliq, discusses the benefits of EyeSol, the company’s water-free technology, over traditional water-based technologies. The firm currently has…

Read More
Nicox’s Big Bet on Nitric-Oxide Platform

Nicox’s Big Bet on Nitric-Oxide Platform

By OIS Contributor | July 17, 2019

Nicox SA CEO and chairman Michele Garufi describes the company’s glaucoma-focused pipeline, drawing on its nitric-oxide platform. He explains how NO works in animal models…

Read More
Alcon Utilizes Internal, External Skill Sets

Alcon Utilizes Internal, External Skill Sets

By OIS Contributor | July 17, 2019

Laurent Attias, SVP of freshly spun-off Alcon, talks up an agnostic approach to innovation in this interview with OIS TV’s Ehsan Sadri, MD, adding the…

Read More
Daniel Durrie

Daniel Durrie, MD

By Jackie Wengrod | April 15, 2019

Dr. Daniel Durrie is an internationally recognized refractive surgeon and has performed over 50,000 refractive procedures in his career. He is the founder of Durrie…

Read More

Allegro Ophthalmics – Innovation Showcase at Ophthalmology Innovation Summit @ AAO 2019

By Healthegy Admin | March 7, 2019

Susan Orr, CEO speaks for Notal Vision during the Innovative Showcase at OIS@AAO 2019. REGISTER for our next ophthalmology conference today http://bit.ly/2yFA6cv.

Read More

Companies to Watch: Vizzario

By Mario Admin | January 24, 2018

Vizzario is developing an artificial intelligence platform that performs computer modeling of common eye diseases. Founder and CEO Khizer Khaderi, MD, a neuro-ophthalmologist, explains that…

Read More

Mitro Points Out Path to Aerie

By Mario Admin | December 17, 2017

In addition to bringing us up to date on Aerie Pharmaceuticals’ progress, Thomas A. Mitro, president and COO, sheds some light on his path to…

Read More

Hess Highlights Surging Platforms at Bausch + Lomb

By Mario Admin | December 17, 2017

Chuck Hess, vice president and general manager at Bausch + Lomb, updates us on the company’s growing Stellaris Elite and Vitesse platforms as well as…

Read More

Mitchell Sees Strong Growth at AcuFocus

By Mario Admin | December 17, 2017

Yari Mitchell, vice president of medical affairs and business strategy at AcuFocus, updates OIS.TV on the progress of the Kamra Inlay and the promise of…

Read More

Van Meter Says Ivantis Making Moves in MIGS

By Mario Admin | December 17, 2017

Dave Van Meter, president and CEO of Ivantis, explains how the company’s Hydrus Microstent plans to grab a piece of the growing MIGS market. He…

Read More

Frinzi Shares Milestones for Symfony, Looks at the Next Decade of Innovation

By Mario Admin | December 17, 2017

Thomas Frinzi, worldwide president, surgical, Johnson & Johnson Vision, shares some impressive milestones for the company’s Symfony and Symfony Toric IOLs. He also discusses the…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.